We have previously demonstrated that the reduced form of vitamin C (L-ascorbic acid, AA) is able to induce the production of both steroid and peptide hormones in human choriocarcinoma cells. Here, we attempted to investigate the role and underlying mechanism of the oxidized form of vitamin C, dehydroascorbic acid (DHA), in steroidogenesis in primary human cytotrophoblasts and human choriocarcinoma cells. Messenger RNA and protein levels of steroidogenic enzymes including P450 cholesterol side-chain cleavage enzyme (P450scc), 3b-hydroxysteroid dehydrogenase type 1 (3b-HSD1), 17b-hydroxysteroid dehydrogenase type 1 (17b-HSD1) and aromatase were examined by quantitative RT-PCR and western blots, respectively. Progesterone (P4) and estradiol (E2) levels were determined by enzyme immunoassays. Knockdown of c-Jun was achieved by lentivirus-mediated shRNA, and signaling pathways implicated in DHA-induced steroidogenesis were examined by western blots and dual-luciferase assays. DHA dose-dependently induced the expression of steroidogenic enzymes including 3b-HSD1, 17b-HSD1 and aromatase at both mRNA and protein levels, and subsequently increased the production of E2 but not P4. These effects were synergized by diethylmaleate, a glutathione-depleting compound, and a-tocopherol, a reducing agent, but robustly attenuated by inhibition of DHA transportation by phloretin or 2-deoxy-D-glucose. DHA time-dependently inhibited JNK and c-Jun phosphorylation, and dose-dependently reduced AP1 reporter activity. JNK signaling pathway-specific inhibitor SP600125 and c-Jun shRNA both significantly increased the expression of steroidogenic enzymes and E2 production regardless of the presence or absence of DHA. These findings suggest that DHA is able to induce steroidogenesis through inhibition of JNK/c-Jun/AP1 signaling, and may therefore play indispensable roles in pregnancy maintenance.
Introduction
The placenta is a temporary organ that connects the fetus to the maternal body. Its role in maternal and fetal physiology is remarkably diverse; in addition to allowing for nutrient uptake, gas exchange and waste elimination by the developing fetus, placenta produces various hormones that are essential for pregnancy maintenance and embryo development (John and Hemberger, 2012) . Among these hormones, steroids including progesterone (P4) and estradiol (E2) are of most importance; it has been reported that by 7th week of gestation, nearly all circulating P4 and E2 in pregnant women are produced by placenta (Hill et al., 2010) .
Human placental P4 and E2 biosynthesis involves various steroidogenic enzymes. Placental P4 is synthesized through sequential conversions of cholesterol to pregnenolone and pregnenolone to P4 catalyzed, respectively, by P450 cholesterol side-chain cleavage enzyme (P450scc) and type 1 3b-hydroxysteroid dehydrogenase (3b-HSD1) (Payne and Hales, 2004; Wu et al., 2008) . Placental E2 is generated either through 3b-HSD1-catalyzed conversion of C19 androgens such as dehydroepiandrosterone (DHEA) derived from the fetus and maternal adrenal glands to A-dione and aromatase-catalyzed conversion of A-dione to E2 subsequently or alternatively through aromatase-catalyzed conversion of C19 androgens to C18 estrone and subsequent conversion of † These authors contributed equally to this work.
estrone to a more active hormone, E2, catalyzed by 17b-HSD1 (Payne and Hales, 2004; Wu et al., 2008) .
It is well-established that vitamin C supplementation is capable of reducing the risk of pregnancy complications such as pre-eclampsia and intrauterine growth restriction and thus benefits human pregnancy (Henmi et al., 2003; Rumbold et al., 2011; Swaney et al., 2014) . Vitamin C exists in the human body in a reduced form, L-ascorbic acid (AA), and/or an oxidized form, L-dehydroascorbic acid (DHA). AA is transported into cells via sodium-dependent vitamin C transporters (SVCTs) 1 and 2, while DHA competes with glucose through various isoforms of the facilitative glucose transporters (GLUTs) (Sotiriou et al., 2002; Wilson, 2005) . AA is converted to DHA by oxidative reaction, and DHA is reduced back to AA by NADPH-dependent thioredoxin reductase or glutathione-dependent DHA reductase in many cell types (May, 2002) . This is exemplified by astrocytes which accumulate DHA in intracellular space and release AA after intracellular reduction (Daskalopoulos et al., 2002) . AA is present at high concentrations in the pituitary, adrenal gland and gonads, indicating a significant importance in hormone synthesis (Levine and Morita, 1985) . We have previously demonstrated that AA may induce the production of steroid hormones including P4 and E2 by increasing the transcription of several steroidogenic enzyme genes (Wu et al., 2008) , and that it induced the expression of peptide hormone, human chorionic gonadotrophin (hCG)b, through transactivation of specificity protein-1 (Sp1) and transcription factor activating enhancer-binding protein 2a_(TFAP2A) transcription factors (Chen et al., 2012) .
In human placenta, because GLUTs are abundantly expressed, and DHA can be restored to AA in a similar way to that in the brain (Choi and Rose, 1989; May, 2002) , DHA is considered to be important for pregnant maintenance. Pregnancy is a condition where there is an increased susceptibility to oxidative stress. As a result, maternal AA is gradually consumed and DHA accumulates as the embryo continues to grow. In addition, in patients with gestational hypertension, the AA deficiency is exacerbated even before pre-eclampsia due to high levels of oxidative stress (Chappell et al., 2002a, b; Saker et al., 2008; Klemmensen et al., 2009) . All these pieces of evidence prompt us to assume that the biological functions of DHA might be even more complicated than those of AA, and that DHA may play some important roles not only in normal but also in abnormal pregnancies through regulating endocrine activities of the placenta. In the present study, we aimed to investigate the effects of DHA on placental steroidogenesis and the underlying molecular mechanisms using primary cytotrophoblasts and JAR cells as models which have been previously used to study human placental endocrinology in vitro (Nakanishi et al., 2002; McDonald and Wolfe, 2009 ).
Materials and Methods

Cell culture and reagents
Human choriocarcinoma JAR cells were obtained from ATCC (Manassas, VA, USA), and were cultured as described previously (Nakanishi et al., 2002; Wu et al., 2008) . In all experiments, cells were pre-cultured for 24 h in Roswell Park Memorial Institute (RPMI)-1640 medium (Life Technologies Co., Grand Island, NY, USA) containing 10% fetal bovine serum (FBS), and then treated with DHA ranging from 1 to 100 mM (Sigma, St. Louis, MO, USA) and various chemicals (described below) in RPMI-1640 containing 5% charcoal-stripped FBS (Life Technologies Co.). Media containing either DHA-or chemicals were not replaced, until the cells were harvested for various measurements. For preparation of c-Jun shRNA-expressing lentiviruses, 293FT packaging cells (Life Technologies Co.) were cultured according to the manufacturer's instructions. For investigation of the signaling pathway, JAR cells were starved for 12 h before treatment with DHA. The chemicals in these experiments included the glutathione-depleting compound, diethylmaleate (DEM, Aladdin Reagent Co., Shanghai, China), the reducing agent, a-tocopherol (a-TCP, Sigma), the analogue of glucose, 2-deoxy-D-glucose (2-DG, Sigma), the c-Jun N-terminal kinase (JNK) inhibitor, SP600125 (Sigma), the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059 (Sigma), and the GLUTs inhibitor, phloretin (Sigma).
Isolation and culture of primary human cytotrophoblasts
In addition to JAR cells, normal primary cytotrophoblasts were utilized in this study. These were isolated from full-term (38-40 weeks) human placenta obtained from uncomplicated pregnancies within 30 min after elective Cesarean deliveries as described previously (Chen et al., 2012) . The reason for using term rather than first trimester placenta is that first trimester and term cytotrophoblasts have been demonstrated to have similar endocrine activities in terms of hCGb, hCGa and P4 secretion upon cyclic adenosine monophosphate (cAMP) stimulation despite subtle differences in other aspects (Kato and Braunstein, 1990) . Isolated cytotrophoblasts were cultured in Dulbecco's modification of Eagle's medium (DMEM) supplemented 10% fetal calf serum at 378C in 5% CO 2 and 95% air. The procedures for placenta collection and cytotrophoblast isolation were reviewed and approved by the Ethics Committee of Zhejiang University School of Medicine. A written consent was obtained from all participating patients.
P4 and E2 measurements
The primary cytotrophoblasts and JAR cells were seeded in 24-well plates at a density of 5 × 10 4 cells per well. After 24 h pre-culture, cells were treated with DHA for 48 h, and then were cultured for an additional 4 h in serum-free medium containing either 20 mg/ml 25-hydroxycholesterol (Sigma Aldrich) for P4 determination, or 10 mM 4-androstene-3,17-dione (Sigma Aldrich) for E2 determination. The culture supernatants were harvested, and the levels of P4 and E2 were determined by P4 and E2 Correlate-Enzyme Immunoassay (EIA) kits (Assay Designs, Ann Arbor, MI, USA), respectively.
Quantitative real-time RT-PCR and regular RT -PCR
The cytotrophoblasts and JAR cells were seeded in 10-cm dishes at a density of 5 × 10 5 cells/dish. After pretreatment with or without indicated chemicals for 1 h, the cells were incubated with DHA for further 48 h. Total RNA was extracted using TRIzol reagent (Takara Biotechnology Co., Ltd. Dalian, China). Messenger RNA levels of steroidogenic enzymes were determined by quantitative RT-PCR as described previously (Wu et al., 2008) . The relative amounts of the mRNA levels of the steroidogenic enzymes were normalized to the GAPDH levels, respectively, and the relative difference in mRNA levels was calculated by 2 2DDCt method (Livak and Schmittgen, 2001 ). For the regular RT-PCR, diluted RT products were amplified with Taq DNA Polymerase (Takara) using the PCR conditions and primer pairs as described in Supplementary data, Table SI . The PCR products were electrophoresed in 1% agarose gels and visualized by ethidium bromide staining.
Western blot
After various treatments, the whole cell lysates were prepared by using radioimmunoprecipitation assay (RIPA) lysis buffer (Beyotime, Haimen, China), and the lysates containing 40 mg of protein were subjected to SDS -PAGE in a 10% gel and transferred to a polyvinylidene fluoride (PVDF) membrane. Immunoblotting was performed with indicated first antibody and immunofluorescent second antibody, and was visualized with Odyssey Infrared Imaging System (LI-COR, Lincoln, NE, USA). b-Actin and a-tubulin were used as internal standards. The anti-a-tubulin and anti-b-actin antibodies were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA); antiaromatase, anti-p-extracellular regulated protein kinases (ERK)1/2, anti-p-c-Jun N-terminal kinases (JNK), anti-ERK1/2, anti-JNK, anti-p-c-Jun (S73) and anti-c-Jun antibodies were from Cell Signaling Technology, Inc.
(Danvers, MA, USA); anti-3b-HSD1 and anti-17b-HSD1 antibodies were from Abcam Ltd (Cambridge, UK). Image software (ImageJ) from National Institutes of Health (http://rsb.info.nih.gov/ij/download.html) was used to quantify the immunoreactive bands, and the mean density of the first band was set to 1.
Dual-luciferase assay
The dual-luciferase reporter assay was performed as described previously (Chen et al., 2012) . Briefly, the JAR cells were seeded in 24-well plates at a density of 4 × 10 4 cells/well, and were transfected by using Atractene (Qiagen, Valencia, CA, USA) reagents according to the manufacturer's instructions. Six hours after transfection, the cells were changed to fresh medium containing DHA at 10 and 100 mM. After incubation for 48 h, dualluciferase reporter assay (Promega, Madison, WI, USA) was performed. The renilla luciferase activity was used as an internal standard; the reporter constructs in these experiments were kindly provided by Prof. Linrong Lu from Institute of Immunology, Zhejiang University.
Generation of c-Jun-shRNA-expressing lentiviruses
For construction of lentiviral shRNA-expressing vectors, the hairpin shRNA templates of complementary oligonucleotide containing overhangs were digested. The synthesized complementary oligonucleotides were annealed and inserted into the XbaI and NotI sites of a lentiviral shRNA expression vector, pLL3.7 (Life Technologies Co.). The integrity of the shRNA-expressing constructs was verified by a DNA sequencer. The sense sequence for c-Jun was 5 ′ -TGCAGTTGCAAACATTTTTCAAGA GAAAATGTTTGCAACTGCTGCTTTTTT C-3 ′ , and the antisense sequence was 5
′ -TCGAGAAAAAAGCAGCAGTTGCAAACATTTTCT CTTGAAAAATGTTTGCAACTGCTGCA-3 ′ ; the sense sequence for negative control was 5 ′ -TAAAGA GTAGGTAAGAGGCCTTCAAGAGA GGCCTCTTACCTACTCTTTTTTTTTC-3 ′ , and the antisense sequence was 5
′ -TCGAGAAAAAAAAAGAGTAGGTAAGAGGCCTCTCTT GAA GGCCTCTTACCTACTCTTTA-3 ′ . 293FT packaging cells were transfected with 6 mg of each construct by Lipofectamine reagents (Life Technologies Co.), 72 h after transfection, lentivirus-containing supernatants were harvested, and the lentiviruses with titers more than 1 × 10 6 colony forming U/ml were used for infection.
Statistics
Numerical data were expressed as means + standard deviation (SD) from 4 independent experiments, and each experiment was assayed in triplicate. The statistical assays were performed by One-Way ANOVA and TukeyKramer multiple comparisons test (SPSS 13.0J software, SPSS, Inc., Chicago, IL, USA), and the significance was assessed at P , 0.05.
Results
Effects of DHA on E2 and P4 production in cytotrophoblasts and JAR cells
The steroidogenic effects of DHA were examined in both primary cytotrophoblasts and JAR cells. Treatment with DHA at 1, 10 and 100 mM for 48 h only slightly increased the production of P4 in both cytotrophoblasts and JAR cells (P . 0.05, Figs 1A and 2A). In contrast, DHA robustly increased E2 production in a dose-dependent manner; at 100 mM the Figure 1 Induction of steroidogenesis by dehydroascorbic acid (DHA) in primary human cytotrophoblasts. Human cytotrophoblasts were incubated with the indicated concentrations of DHA for 48 h, and then were subjected to determination of progesterone (P4) and estradiol (E2) levels in the culture medium (A and B), isolation of total RNA for quantitative RT-PCR of the steroidogenic enzymes, P450 cholesterol side-chain cleavage enzyme (P450scc), 3b-hydroxysteroid dehydrogenase type 1 (3b-HSD1), 17b-hydroxysteroid dehydrogenase type 1 (17b-HSD1) and aromatase (C-F) and preparation of protein lysates for western blots (G). The data are mean + SD from four independent experiments. In (C) -(G) mRNA or protein levels are expressed relative to 0 mM DHA which was set as 1, *P , 0.05, **P , 0.01 versus 0 mM DHA.
Dehydroascorbic acid in steroidogenesis increase was 4.6-fold and 7.8-fold in cytotrophoblasts and JAR cells, respectively (Figs 1B and 2B).
Effects of DHA on the expression of steroidogenic enzymes in cytotrophoblasts and JAR cells
To evaluate the possible involvement of steroidogenic enzymes in placental steroidogenesis in the presence of DHA, we assessed changes in mRNA and protein levels of P450scc, 3b-HSD1, 17b-HSD1 and aromatase in primary cytotrophoblasts and JAR cells after DHA treatment.
In agreement with changes in E2 and P4 concentrations, DHA treatment for 48 h robustly increased mRNA levels of 3b-HSD1, 17b-HSD1 and aromatase (Figs 1D-F and 2D-F) in a dose-dependent manner in both cytotrophoblasts (3.3, 2.7 and 2.0 folds, respectively, at 100 mM) and JAR cells (2.4, 2.2, and 2.3 folds, respectively, at 100 mM), but only slightly increased mRNA levels of P450scc ( Figs 1C and 2C ). Protein levels of 3b-HSD1, 17b-HSD1 and aromatase changed in a similar pattern; they were increased 3.5, 4.2 and 2.7 folds, respectively, in cytotrophoblasts ( Fig. 1G ) and by 3.2, 2.5 and 2.3 folds, respectively, in JAR cells (Fig. 2G) after DHA treatment at 100 mM.
GLUTs-mediated steroidogenesis stimulated by DHA
To determine the potential role of DHA transporters, GLUTs, in DHA-induced steroidogenesis, first we examined the expression of subtypes of GLUT in JAR cells by RT -PCR. GLUT1, 3 and 4 were robustly expressed in the JAR cells, whereas GLUT2 was at undetectable level in current RT-PCR conditions (Fig. 3A) . Then, we investigated the effects of either functional inhibition of GLUTs by phloretin or competitive inhibition of DHA transportation by 2-DG on DHA-induced gene expression of steroidogenic enzymes in JAR cells. DHA at 100 mM alone robustly induced the mRNA levels of 3b-HSD1, 17b-HSD1 and aromatase, whereas either phloretin at 50 mM or 2-DG at 10 mM not only significantly attenuated DHA-induced mRNA levels of steroidogenic enzymes (Fig. 3B -D and F-H), but also significantly suppressed DHA-induced E2 production ( Fig. 3E and I ).
Effects of redox status on DHA-induced expression of steroidogenic enzymes DHA acts as an either oxidizing or reducing agent depending on the intracellular redox status. To investigate the effects of intracellular redox status on DHA-induced steroidogenesis, we treated cells with either 100 mM DEM to deplete intracellular GSH or 100 mM a-TCP to protect the cell from oxidative stress, and further examined the steroidogenic effects of DHA at 100 mM. DHA alone significantly induced increases in mRNA and protein levels of 3b-HSD1, 17b-HSD1, and aromatase, and DEM or a-TCP also increased mRNA levels of these enzymes but to a lesser extent than DHA (Fig. 4A -F) . Unexpectedly, treatment with either DEM or a-TCP significantly potentiated DHA-induced both mRNA and protein levels of these steroidogenic enzymes ( Fig. 4A-F) . Moreover, either DEM or a-TCP further potentiated DHA-induced E2 production in JAR cells ( Fig. 4I and J) . in JAR cells. JAR cells were incubated with the indicated concentrations of DHA for 48 h, and then were subjected to determination of progesterone (P4) and estradiol (E2) levels in culture medium (A and B), isolation of total RNA for quantitative RT-PCR of the steroidogenic enzymes, P450 cholesterol side-chain cleavage enzyme (P450scc), 3b-hydroxysteroid dehydrogenase type 1 (3b-HSD1), 17b-hydroxysteroid dehydrogenase type 1 (17b-HSD1) and aromatase (C-F) and preparation of protein lysates for western blots (G). The data are mean + SD from four independent experiments. In (C)-(G) mRNA or protein levels are expressed relative to 0 mM DHA which was set as 1, *P , 0.05, **P , 0.01 versus 0 mM DHA.
Involvement of JNK/c-Jun/AP1 signaling in DHA-induced steroidogenesis
Activator protein (AP)1, a transcription factor which is a heterodimeric complex composed of proteins belonging to the c-Fos, c-Jun, ATF and JDP families, not only regulates gene expression in response to oxidative stress (Finkel, 2011; Liu et al., 2011) , but also transactivates steroidogenic genes (Abidi et al., 2004; Guo et al., 2007) .
To determine the effects of DHA on AP1 transactivity, we assessed AP1 reporter activity by dual-luciferase assays. DHA dose-dependently negated AP1 luciferase activities (by 60% at 100 mM, Fig. 5A ).
To further determine the upstream events mediating DHA downregulation of AP1 transactivity, we examined the kinase activities of MAPK and phosphorylation levels of c-Jun by western blots. DHA at 100 mM time-dependently and robustly induced ERK1/2 phosphorylation with the maximal induction (3.5-fold) observed at 60 min after stimulation (Fig. 5B) . In contrast, DHA at 100 mM time-dependently attenuated JNK phosphorylation with the maximal inhibition (by 50%) observed at 180 min after stimulation (Fig. 5D ). However, DHA failed to affect P38 phosphorylation (Fig. 5C ). Consistent with that DHA-induced reduction in JNK activity, DHA at 100 mM robustly and time-dependently down-regulated c-Jun phosphorylation with the maximal inhibition (by 70%) observed at 180 min after stimulation (Fig. 5E) . To determine the possible involvement of JNK/c-Jun and ERK1/2 signaling pathways in DHA regulation of steroidogenesis, we examined the effects of JNK-specific inhibitor, SP600125, and MEK1/ 2-specific inhibitor, PD98059, on DHA-induced changes in mRNA levels of these steroidogenic enzymes by quantitative RT -PCR. SP600125 alone significantly increased 3b-HSD1 and aromatase . JAR cells were pretreated with either 50 mM phloretin, 10 mM 2-deoxyglucose (2-DG) or an equal volume of dimethyl sulphoxide (vehicle) for 1 h, before incubation with either 0 or 100 mM DHA. After treatment for 48 h, cells were subjected to determination of mRNA levels of 3b-hydroxysteroid dehydrogenase type 1 (3b-HSD1) (B and F), 17b-hydroxysteroid dehydrogenase type 1 (17b-HSD1) (C and G) and aromatase (D and H), and of E2 levels (E and I). The data are mean + SD from four independent experiments; mRNA levels (B -D, F -H) are expressed relative to 0 mM DHA which was set as 1, *P , 0.05, **P , 0.01 versus 0 mM DHA. *P , 0.05, **P , 0.01 versus treatment with vehicle and 0 mM DHA. † P , 0.05, † † P , 0.01 versus treatment with vehicle and 100 mM DHA.
Dehydroascorbic acid in steroidogenesis mRNA levels; however, SP600125 and DHA synergistically induced the mRNA levels of not only 3b-HSD1, but also 17b-HSD1 and aromatase ( Fig. 5F -H) . PD98059 alone failed to affect the mRNA levels of 3b-HSD1, 17b-HSD1 and aromatase, whereas PD98059 together with DHA significantly increased the mRNA levels of 17b-HSD1 alone (Fig. 5I-K) . Figure 4 Effects of redox status on dehydroascorbic acid (DHA)-induced steroidogenesis in JAR cells. JAR cells were pre-treated with either 100 mM diethylmaleate (DEM) or 100 mM a-tocopherol (a-TCP) for 1 h, before incubation with or without 100 mM DHA for 48 h. After treatment, cells were subjected to determination of the mRNA levels of 3b-hydroxysteroid dehydrogenase type 1 (3b-HSD1) (A and D), 17b-hydroxysteroid dehydrogenase type 1 (17b-HSD1) (B and E) and aromatase (C and F) by quantitative RT -PCR, of the protein levels of 3b-HSD1, 17b-HSD1 and aromatase by western blots (G and H), and of the E2 levels in culture medium by EIA (I and J). The relative mRNA and protein levels from cells treated with vehicle and 0 mM DHA were set as 1. The data were expressed as mean + SD from four independent experiments. *P , 0.05, **P , 0.01 versus treatment with vehicle and 0 mM DHA. † P , 0.05, † † P , 0.01 versus treatment with vehicle and 100 mM DHA.
Effects of c-Jun silencing on DHA-induced steroidogenesis
To determine further the inhibitory effects of JNK/c-Jun/AP1 signaling on DHA-induced steroidogenesis, we assessed mRNA levels of steroidogenic enzymes in JAR cells infected with c-Jun shRNA-expressing lentiviruses in either the presence or absence of DHA. DHA treatment at 100 mM for 48 h did not increase c-Jun protein levels, whereas c-Jun shRNA-expressing lentiviruses led to decreases, 70-80% in protein AP1 reporter constructs and pRL-null Renilla luciferase constructs, and after treatment with DHA for 48 h, cells were harvested for dual-luciferase assay (A). After starvation for 12 h, JAR cells were incubated with 100 mM DHA for indicated times, and the cell lysates were subjected to western blot assays for detecting the levels of p-ERK1/2 and ERK1/2 (B), p-P38 and P38 (C), p-JNK and JNK (D), p-c-Jun and c-Jun (E). The normalized antigen signals were calculated from p-ERK1/2-, p-P38-, p-JNK-or p-c-Jun-derived and ERK1/2-, P38-, JNK-or c-Jun-derived signals. JAR cells were pre-treated with 10 mM SB600125, 10 mM PD98059 or equal volume of dimethyl sulphoxide (vehicle) for 1 h before incubation with either 0 or 100 mM DHA. After treatment for 48 h, cells were subjected to determination of mRNA levels of 3b-hydroxysteroid dehydrogenase type 1 (3b-HSD1) (F and I), 17b-hydroxysteroid dehydrogenase type 1 (17b-HSD1) (G and J) and aromatase (H and K) by quantitative RT-PCR. The relative luciferase activities from 0 mM DHA, the mean density of west blot bands from 0 min treatment, and the relative mRNA levels from treatment with vehicle and 0 mM DHA were set as 1. The data were expressed as mean + SD from four independent experiments. *P , 0.05, **P , 0.01 versus treatment with vehicle and 0 mM DHA. † P , 0.05, † † P , 0.01 versus treatment with vehicle and 100 mM DHA.
levels of c-Jun in either the presence or absence of DHA (Fig. 6A ). In the absence of DHA, knockdown of c-Jun expression significantly increased not only the mRNA levels of 3b-HSD1, 17b-HSD1 and aromatase, but also the production of E2 (Fig. 6B -E) . DHA treatment in combination with c-Jun gene silencing synergistically increased the mRNA levels of these steroidogenic enzymes and the production of E2 as expected ( Fig. 6B -E) .
Discussion
To the best of our knowledge, this study is the first work on the molecular mechanism underlying DHA-induced steroidogenesis in human choriocarcinoma cells. In the molecular cascade of this regulated steroidogenesis, DHA is taken up by GLUTs, resulting in intracellular inhibition of JNK/c-Jun/AP1 signaling and subsequent increases in steroidogenic enzyme expression and E2 production. AA is associated with hormone synthesis and maintenance of pregnancy (Levine and Morita, 1985; Henmi et al., 2003; Rumbold et al., 2011; Swaney et al., 2014) . Given the gradual decrease in serum concentrations of AA with gestation stages (dropping from 62.5 mM at the beginning of the pregnancy to 28.4 mM after 4-month gestation and further to 19.9 mM before labor, Henmi et al., 2003; Rumbold et al., 2011) , AA administration at least 200 mg/day has been recommended for pregnant women to maintain the saturated serum concentration at 60 mM. In normal and AA-deficient pregnancies, the circulating concentration of AA is higher in the fetus than in the mother (Chappell et al., 2002a; Saker et al., 2008; Klemmensen et al., 2009) , whereas intense oxidative stress induces an increase in AA to DHA conversion in late gestational stages. To provide sufficient AA to meet fetal demand, in human placenta, vitamin C is transported predominantly in the form of DHA (Choi and Rose, 1989; Perez et al., 2008; Klemmensen et al., 2009) . This is most likely because the uptake of DHA on both the fetal and the maternal sides is 3-6 times higher than that of AA. As a result, DHA is believed to be equally important as AA.
In the present study, DHA significantly induced both the expression of 3b-HSD1, 17b-HSD1, and aromatase at both mRNA and protein levels and led to robust increases in E2 in both primary human cytotrophoblasts and JAR cells. This observation strongly suggests that up-regulating the expression of steroidogenic enzyme genes is essential for adequate E2 biosynthesis. We have previously demonstrated that AA is able to induce both P4 and E2 production through increasing the transcription of P450scc, 3b-HSD1 and aromatase but not 17b-HSD1 in JEG-3 cells (Wu et al., 2008) . Given the clearly distinct effects of DHA and AA on steroidogenesis in human choriocarcinoma cells, we speculate that DHA-induced steroidogenesis is unlikely to be through intracellular reduction to AA, and that DHA and AA may exert their steroidogenic effects in human placenta through different mechanisms. In line with this speculation, previous findings reported that DHA could be reduced to AA or readily hydrolyzed and oxidized, making it an oxidizing and reducing agent as well (Deutsch, 2000; Lowes et al., 2010) .
GLUTs are responsible for the transportation of not only glucose but also DHA (Wilson, 2002) , and are abundantly expressed in human placenta. While GLUT1 and GLUT 3 are present in villous cores and cytotrophoblasts of the first trimester placenta (Ericsson et al., 2005) and villous syncytiotrophoblasts and the endothelium of vessels as well as cytotrophoblasts of the term placenta (Gao et al., 2012) , GLUT4 is in the syncytiotrophoblasts (Ericsson et al., 2005) . In this study, mRNA species of GLUT1, GLUT3 and GLUT4 were detected in JAR cells. Phloretin, a GLUT inhibitor, blocked the transportation of DHA, and nearly obliterated the up-regulation of steroidogenic enzyme gene transcription and E2 production in response to DHA, suggesting an essential role for GLUTs-mediated DHA uptake in DHA-induced steroidogenesis in JAR cells. Because phloretin also acts as an inhibitor of aquaporin 9, SVCT1 and chloride channel 3 in addition to GLUTs (Tsukaguchi et al., 1999) , we further assessed whether 2-DG, an analogue of glucose, was able Figure 6 Increases in steroidogenesis by knockdown of c-Jun expression in JAR cells. JAR were infected with either control shRNA-(Ctrl.) or c-Jun shRNA-expressing lentiviruses for 24 h. After treatment with dehydroascorbic acid (DHA) for 48 h, the cells were subjected to determination of c-Jun protein levels (A) by western blots, mRNA levels of steroidogenic enzymes (B -D) by quantitative RT-PCR, and estradiol (E2) levels by enzyme immunoassay (E). b-Actin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were used as internal standards for western blot and quantitative RT-PCR, respectively, and the protein and mRNA levels derived from cells infected with control shRNAexpressing lentiviruses and treated with 0 mM DHA were set as 1. The data were expressed as mean + SD from four independent experiments. **P , 0.01 versus infection with control shRNA-expressing lentiviruses and treatment with 0 mM DHA. † P , 0.05, † † P , 0.01 versus infection with control shRNA-expressing lentiviruses and treatment with 100 mM DHA.
to competitively inhibit the transportation of DHA and thus affect DHA-induced steroidogenesis. Similar to phloretin, 2-DG almost completely abrogated the DHA-induced up-regulation of steroidogenic enzyme gene expression and E2 production, further supporting that DHA uptaken by GLUTs may induce the steroidogenesis in JAR cells. However, since blocking the uptake of DHA by phloretin and 2-DG suppresses the glucose uptake, we are still unable to exclude the possibility that blocking the glucose uptake might disrupt the energy metabolism and so limit steroid production. SVCT2 is predominantly expressed in human first-trimester chorionic villi but not in term placental tissue (Biondi, et al., 2007) , and SVCT-mediated AA uptake possesses a lower efficacy than GLUTs-mediated DHA uptake in human placenta (Streeter and Rosso, 1981; Rybakowski et al., 1995) . Thus, GLUTsmediated DHA uptake possibly plays a key role in maintaining high concentrations of AA in the fetus in late stage of gestation. A previous study indicated that DHA inhibited IKK-b activity, leading to the suppression of NF-kB transactivity (Carcamo et al., 2004) . In the present study, DHA inhibited both JNK/c-Jun phosphorylation and AP-1 transactivity, suggesting that JNK/c-Jun/Ap1 signaling might be inhibitory in DHA-induced steroidogenesis. This was consistent with our findings that either inhibition of JNK by SP600125 or knockdown of c-Jun by c-Jun shRNA led to the induction of steroidogenic enzyme gene expression and E2 production in the presence or absence of DHA. These observations would allow us to conclude that DHA may suppress JNK/c-Jun/ AP1 signaling, leading to lifting a restriction on gene transcription of steroidogenic enzymes including 3b-HSD1, 17bHSD1 and aromatase. In addition, DHA failed to affect P38 activation, suggesting that P38 might not be the upstream target of c-Jun/AP1 activation. Though DHA robustly induced ERK1/2 phosphorylation, inhibition of MEK1/2 by PD98059 did not significantly decrease DHA-induced mRNA levels of 3b-HSD1 and aromatase, suggesting that neither ERK1/2 nor P38 might be the upstream target of c-Jun/AP1 signaling.
When DHA is transported into trophoblasts, it is immediately converted to AA by NADPH-dependent thioredoxin reductase or glutathione-dependent DHA reductase (May, 2002) . Reduction of DHA to AA 'snatches electrons' from intracellular components, generating a mild oxidative stress, such that DHA has been regarded as an intracellular 'pro-oxidant' (Deutsch, 2000; Montel-Hagen et al., 2008; Toohey, 2008) . On the other hand, DHA can be intracellularly hydrolyzed to diketogulonic acid (DKG) and then oxidized to various metabolites, making DHA a reducing agent (Deutsch, 2000; Chiu et al., 2010; Lowes et al., 2010) . Based on these events, we supposed that intracellular redox status could affect the DHA-induced steroidogenesis. Supporting this notion, we observed that either depletion of GSH by DEM or addition of a reducing agent, a-TCP, potentiated DHA-induced steroidogenesis, suggesting that in the presence of DEM, DHA might work as an oxidant to potentiate DEM-induced steroidogenesis and that in the presence of a-TCP, DHA might work as a reductant to potentiate a-TCP-induced steroidogenesis. JNK/c-Jun/AP1 is a well-established signaling pathway in response to intracellular oxidative stress. Production of reactive oxygen species (ROS) stimulates JNK/c-Jun/AP1 activities and reduction of ROS production by reductants, such as AA and a-TCP, attenuates their activation (Evans et al., 2002; Carcamo et al., 2004; Finkel, 2011) . In the present study, DHA stimulated steroidogenesis through suppression of JNK/c-Jun phosphorylation and subsequent decreases of AP-1 transactivity. Thus, we suggest that the anti-oxidative effects of DHA itself but not its intracellular conversion to AA, reduced intracellular ROS production and subsequently inhibited ROS-induced JNK/c-Jun/AP-1 activation, which led to the induction of gene transcription of steroidogenic enzymes. Alternatively, as DHA directly inhibits the IKK-b activation, and leads to the subsequent suppression of NF-kB transactivity (Carcamo et al., 2004) , DHA might also directly inhibit the JNK activation and lead to the subsequent decreases in AP1 transactivity.
Taken together, the present study revealed that DHA-induced E2 but not P4 production in human choriocarcinoma cells and primary cytotrophoblasts, involving an inhibition of the JNK/c-Jun/AP1 signaling pathway. DHA enters the cell through the glucose transporters and possibly due to antioxidant properties of its own beyond those due to intracellular conversion to AA, suppresses JNK/c-Jun/AP1 signaling cascade, leading to the increases of the expression of 3b-HSD1, 17b-HSD1 and aromatase, which accelerate the synthesis of E2 (Fig. 7) .
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